- Venture Life has issued its H1 results, the highlights of which are below:

- Revenue increased 40% to £6.1 million (H1 2015: £4.4 million)

- Gross profit increased 47% to £2.3 million (H1 2015: £1.5 million), giving a gross margin of 37% (H1 2015: 35%)

- Adjusted EBITDA profit of £0.1 million (H1 2015: loss of £0.4 million)

- Loss before tax, amortisation and exceptional items of £0.3 million (H1 2015: loss of £0.4 million)

- Cash at period end of £1.6 million (31 December 2015: £2.9 million)

- Acquisition of the UltraDEX oral care products brand with Periproducts Limited in March 2016 for £5.7 million, funded in part by a £1.7 million placing and the issue of a convertible bond raising £1.9 million

- Nine new long term exclusive distribution agreements signed, including: UltraDEX in Spain, Malaysia and China; and Benecol once-a-day liquid sachet in Turkey and Jordan.

At 9:55am: [LON:VLG] Venture Life Group Plc share price was +2p at 54.5p

Story provided by